可溶性致瘤性抑制2（sST2）作为慢性心力衰竭不良后果的预测因子

{"title":"可溶性致瘤性抑制2（sST2）作为慢性心力衰竭不良后果的预测因子","authors":"Kravchenko A.Ya. Kravchenko, Budnevsky A.V. Budnevsky, Chernik T.A. Chernik, Tokmachev R.E. Tokmachev","doi":"10.18565/therapy.2023.1.63-69","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":88780,"journal":{"name":"Therapy (London, England : 2004)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Soluble suppression of tumorigenicity 2 (sST2) as a predictor of adverse outcomes of chronic heart failure\",\"authors\":\"Kravchenko A.Ya. Kravchenko, Budnevsky A.V. Budnevsky, Chernik T.A. Chernik, Tokmachev R.E. Tokmachev\",\"doi\":\"10.18565/therapy.2023.1.63-69\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":88780,\"journal\":{\"name\":\"Therapy (London, England : 2004)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapy (London, England : 2004)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18565/therapy.2023.1.63-69\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapy (London, England : 2004)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18565/therapy.2023.1.63-69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}